Top Abstract Purchase Related
Home
>
Node
>
Subnode

A study of prostatic tissue levels of ceftizoxime, cefoperazone and cefotaxime

Ikeda, S.; Ishibashi, A.; Koshiba, K.

Hinyokika Kiyo. Acta Urologica Japonica 30(8): 1135-1142

1984

ISSN/ISBN: 0018-1994
PMID: 6083722
Document Number: 241500
Prostatic tissue levels and serum levels of Ceftizoxime (CZX), Cefoperazone (CPZ) and Cefotaxime (CTX), after intravenous administration were studied in 82 patients with prostatic hypertrophy, who underwent transurethral surgery. CZX was found to be the most effective for treatment of prostatic infection, since its prostatic tissue level was considerably higher than the others, satisfactorily above the MIC level of most bacteria. The prostatic tissue levels were not correlated with prostate size. The levels in fibromuscular hyperplasia were significantly higher than in glandular hyperplasia.

Document emailed within 1 workday
Secure & encrypted payments

Kataoka, K.; Kaneko, S.; Kurita, T. 1985: Study on the prostatic tissue levels of cefmenoxime (CMX) Hinyokika Kiyo. Acta Urologica Japonica 31(2): 273-279
Lode, H.; Kemmerich, B.; Koeppe, P.; Belmega, D.; Jendroschek, H. 1980: Comparative pharmacokinetics of cefoperazone and cefotaxime Clinical Therapeutics 3(Spec Issue): 80-88
Pulverer, G.; Peters, G. 1982: Efficacy of the new cephalosporin antibiotics cefotaxime, cefoperazone and lamoxactam Die Medizinische Welt 33(17): 642-644
Yamamoto, T.; Yasuda, J.; Tomioka, M.; Kanao, M.; Okada, H. 1986: Study on tissue transfer of ceftizoxime suppository in the field of obstetrics and gynecology Japanese Journal of Antibiotics 39(6): 1504-1508
Fukatsu, H.; Waki, M.; Hatano, Y.; Hiraiwa, S.; Kikuchi, T.; Muramatsu, T.; Yamada, Y.; Nishikawa, E.; Satoh, T.; Honda, N. 1985: A study on the levels of cefoperazone in urological organs Hinyokika Kiyo. Acta Urologica Japonica 31(6): 1085-1091
Ryzhko, I.V.; Tsuraeva, R.I.; Pasiukov, V.V.; Samokhodkina, E.D.; Shcherbaniuk, A.I. 1996: Third generation cephalosporins (cefoperazone, cefotaxime, ceftazidime and ceftriaxone) in the prevention and treatment of experimental plague in albino mice Antibiotiki i Khimioterapiia 41(5): 35-38
Sakata, T.; Nakamura, H.; Yamashita, M.; Shibata, E.; Omagari, K.; Isomura, T.; Akagawa, H.; Hara, H.; Aoyagi, S.; Kosuga, K. 1985: Concentration of ceftizoxime (CZX) in myocardial tissue during cardiopulmonary bypass (CPB) Kyobu Geka. Japanese Journal of Thoracic Surgery 38(9): 713-716
Borderon, J.C.; Prieur, D.; Huguet, B. 1981: Cefotaxime CSF levels in children with purulent meningitis La Nouvelle Presse Medicale 10(8): 580-584
Ruibal, A.; Durán, P.; Ibarz, L.; Fraile, M.; Roca, I.; de Torres Mateos, J.A. 1984: Tissue polypeptide antigen as a marker for prostatic neoplasms. Preliminary study Archivos Espanoles de Urologia 37(5): 399-403
Shio, K.; Matsuda, S.; Kusumoto, C.; Tachibana, S.; Oyabu, H.; Kurisu, S.; Yamamoto, S.; Okada, M.; Nakamura, K. 1984: Concentrations of cefotaxime in serum and myocardial tissue Japanese Journal of Antibiotics 37(6): 1035-1039
Monden, Y.; Fujimoto, Y.; Nakahara, K. 1986: Pharmacokinetics of cefoperazone concentration in human lung tissue Japanese Journal of Antibiotics 39(1): 57-62
Nielsen, K.T.; Madsen, P.O. 1989: Cefoperazone or cefoperazone-sulbactam as perioperative antibiotic prophylaxis in transurethral surgery Journal of ChemoTherapy 1(4 Suppl): 1010-1011
Aksoy, A.M.; Ozsan, M.; Ural, O.; Ekmen, H. 1993: In vitro susceptibility to cefoperazone and sulbactam/cefoperazone combination of bacterial strains isolated from various patient materials Mikrobiyoloji Bulteni 27(3): 216-220
Barth, X.; Hayoun, H.; Rat, P.; Hoen, J.P.; Favre, J.P.; Lombard-Platet, R. 1991: Comparison of 2 antibiotic combinations used for peritonitis. Cefotaxime-clindamycin versus cefotaxime-metronidazole Presse Medicale 20(2): 57-60
Krieg, M.; Bartsch, W.; Herzer, S.; Becker, H.; Voigt, K.D. 1977: Quantification of androgen binding, androgen tissue levels, and sex hormone-binding globulin in prostate, muscle and plasma of patients with benign prostatic hypertrophy Acta Endocrinologica 86(1): 200-215
Håkansson, T.; Raahave, D.; Hansen, O.H.; Pedersen, T. 1993: Effectiveness of single dose prophylaxis with cefotaxime and metronidazole compared with three doses of cefotaxime alone in elective colorectal surgery European Journal of Surgery 159(3): 177-180
Robaczyk, M.G. 2002: Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol Annales Academiae Medicae Stetinensis 48: 283-300
Koga, H.; Tomono, K.; Hirakata, Y.; Kohno, S.; Abe, K.; Kawamoto, S.; Kusano, S.; Tanaka, K.; Morikawa, N.; Sugiyama, H.; Katsumata, T.; Sasayama, K.; Shimoguchi, K.; Hashimoto, A.; Matsumoto, Y.; Inoue, Y.; Ishiguro, M.; Hori, H.; Mashimoto, H.; Dotsu, Y.; Tanaka, H.; Imamura, Y.; Kanda, T.; Hara, K. 1996: Clinical evaluation of sulbactam/cefoperazone for lower respiratory tract infections. Correlation between the efficacy of sulbactam/cefoperazone and beta-lactamase Japanese Journal of Antibiotics 49(8): 800-807
Chiang, S.Ren.; Tang, H.Jen.; Chang, P.Chin.; Cheng, K.Chen.; Ko, W.Chien.; Chen, C.Hua.; Chuang, Y.Ching. 2007: Synergistic antimicrobial effect of cefotaxime and minocycline on proinflammatory cytokine levels in a murine model of Vibrio vulnificus infection Journal of Microbiology Immunology and Infection 40(2): 123-133
Shimokata, K.; Torigai, K.; Kato, M.; Sakai, S.; Nomura, F.; Ito, T.; Saka, H.; Senda, Y.; Torii, Y.; Ito, T. 1988: Effects of cefotaxime single administration and of cefotaxime + fosfomycin administration against respiratory tract infections Japanese Journal of Antibiotics 41(9): 1261-1271